Fed probe launch into med shortage is much needed
News that the Federal Trade Commission is launching a probe of companies that help buy and distribute the bulk of medicines sold to U.S. hospitals is welcome — and hopefully will unravel and inject transparency into a procurement and maintenance process upon which few Americans reflect until they are affected directly by a medicine not being available. Hopefully, what is uncovered will help end medicine shortages or reduce them dramatically, when stacked against supply records compiled perhaps a decade or two ago. According to a report in the Wall Street Journal, the FTC “is ...